Navigation Links
Laboratory detective work points to potential therapy for rare, drug-resistant cancer
Date:2/12/2014

PITTSBURGH, Feb. 13, 2014 University of Pittsburgh Cancer Institute (UPCI) scientists have shown that old drugs might be able to do new tricks.

By screening a library of FDA-approved anticancer drugs that previously wouldn't have been considered as a treatment for a rare type of cancer, UPCI scientists were surprised when they found several potential possibilities to try if the cancer becomes resistant to standard drug treatment.

The discovery, which will be published in the February 15th issue of Cancer Research, demonstrates that high-throughput screening of already FDA-approved drugs can identify new therapies that could be rapidly moved to the clinic.

"This is known as 'drug repurposing,' and it is an increasingly promising way to speed up the development of treatments for cancers that do not respond well to standard therapies," said senior author Anette Duensing, M.D., assistant professor of pathology at UPCI. "Drug repurposing builds upon previous research and development efforts, and detailed information about the drug formulation and safety is usually available, meaning that it can be ready for clinical trials much faster than a brand-new drug."

Dr. Duensing and her team ran the screening on 89 drugs previously approved by the FDA in an attempt to find more treatment options for patients with gastrointestinal stromal tumors (GISTs), which are uncommon tumors that begin in the walls of the gastrointestinal tract. According to the American Cancer Society, about 5,000 cases of GISTs occur each year in the United States with an estimated five-year survival rate of 45 percent in patients with advanced disease.

GISTs are caused by a single gene mutation and can be successfully treated with the targeted therapy drug imatinib, known by the trade name Gleevec. However, about half of the patients treated with Gleevec become resistant to the drug within the first two years of treatment.

After studying how samples of GIST
'/>"/>

Contact: Allison Hydzik
hydzikam@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert  

Page: 1 2

Related biology news :

1. From surgery to laboratory and back again
2. Story tips from the Department of Energys Oak Ridge National Laboratory, February 2014
3. Story tips from the Department of Energys Oak Ridge National Laboratory, January 2014
4. Official opening of wildlife health genetic and forensic laboratory between EcoHealth Alliance and Sabah Wildlife Department
5. New book on mouse models of cancer from Cold Spring Harbor Laboratory Press
6. New book on calcium techniques from Cold Spring Harbor Laboratory Press
7. New book on Signaling by Receptor Tyrosine Kinases by Cold Spring Harbor Laboratory Press
8. New manual from Cold Spring Harbor Laboratory Press on culturing neural cells
9. New eye treatment effective in laboratory tests
10. Medbox Partners with Licensed Medical Cannabis Laboratory and Cultivation Center in Canada
11. Mount Sinai researchers develop first successful laboratory model for studying hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Laboratory detective work points to potential therapy for rare, drug-resistant cancer
(Date:11/4/2014)... newly published research study examining only marketing directed ... fast food restaurants has found that the majority ... exposed to such marketing tactics. , Authored by ... colleagues, the study is the first to examine ... and exterior of fast food restaurants and its ...
(Date:11/4/2014)... VILNIUS, Lithuania , Nov. 4, 2014 /PRNewswire/ ... identification technologies, today announced that the latest version ... place in the Ongoing MINEX evaluation ... interoperability of fingerprint algorithms using the INCITS 378 ... a mandatory requirement in public tenders in ...
(Date:11/3/2014)... 2014  NeuroSigma ® , Inc. (NeuroSigma), a ... focused on commercialization of its non-invasive ... of neurological and neuropsychiatric disorders, announced today that ... a Notice of Allowance for Mexican Patent Application ... NeuroSigma and the Regents of the University of ...
Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
... (UK) are to investigate how lethal viruses attack differently sized ... the door to new methods of pest control. The project, ... grain-infesting Indian meal moth ( Plodia interpunctella ) and a ... and sometimes not. Dr Steve Sait from the University ...
... Virginia Tech released today the results of a new rating ... the risk of concussions. One currently manufactured helmet received ... helmets received the very good "4-star" rating. ... first time researchers have provided the public with comparative test ...
... Palo Alto, CA Accurately calculating the amount of ... bringing products to our doorsteps is nearly impossible, but ... a commentary published online this week by Proceedings of ... Ken Caldeira and Steven Davis commend the work of ...
Cached Biology News:No safety in numbers for moths and butterflies 2Virginia Tech announces football helmet ratings for reducing concussion risk 2Virginia Tech announces football helmet ratings for reducing concussion risk 3Virginia Tech announces football helmet ratings for reducing concussion risk 4Consumption, carbon emissions and international trade 2
(Date:11/26/2014)... -- Theravalues Corporation est fier d,annoncer le lancement ... salon Hi Europe 2014 (du 2 au 4 décembre ... Curcumine la plus biodisponible actuellement sur le marché, ... ingrédients approuvés par les règlements européens. ... la racine de curcuma ( Curcuma longa ) ...
(Date:11/26/2014)... -- Theravalues Corporation annuncia con orgoglio il lancio di ... Hi Europe 2014 (dal 2 al 4 dicembre, ... curcumina con la maggiore biodisponibilità di sempre, con una ... dalle norme europee. La curcumina è un ... Curcuma longa ) che è stata associata con attività ...
(Date:11/24/2014)... Nov. 24, 2014  IGI Laboratories, Inc. (NYSE MKT: ... specialty generic pharmaceutical company, today announced it has submitted ... U.S. Food and Drug Administration (FDA), which brings the ... seven, with eighteen submissions now pending at the FDA. ... CEO of the Company, commented, "Our team here at ...
(Date:11/24/2014)... 24, 2014  Last week, Representatives Gus ... (D-NC) took a bold bipartisan step on behalf ... OPEN Act. Original co-sponsors of the legislation include ... will incentivize drug makers and innovators to "repurpose" ... pediatric cancers, which opens the door to the ...
Breaking Biology Technology:La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 3La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 3IGI Laboratories, Inc. Announces ANDA Submission 2OPEN Act Introduced to Repurpose Drugs for Rare Diseases 2
... 2009 , , ARVADA, Colo., June 16 ... and responsibility to our shareholders, is addressing our recent ... Finance 2009, a Biotechnology, Medical Devices, and world public ... 4-5. , , Pharma Finance is an international ...
... Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ), a ... oncology therapeutics for the treatment of solid and hematologic cancers, ... will be presenting at the Jefferies 3rd Annual Healthcare Conference ... 17, 2009. , , The live webcast of this ...
... SHANGHAI, June 16 /PRNewswire-Asia/ -- Sundia MediTech Company, a,Shanghai-based ... facility in Shanghai has passed the audit from a ... are praised,for providing good facilities and programs for the ... The inspection and audit took place in May. ...
Cached Biology Technology:GeneThera Extends its Reach Overseas 2Sundia's Animal Facility Passed Client and Government Inspection 2
... , Coated Capture Antibody: 12 x 8-well strips, ... mL of 2X concentrate , Beta Amyloid ... , Lyophilized Standard Diluent: 3 mL , Primary ... Antibody-HRP: 30 microL of concentrate , OPD Substrate: ...
Human Cell Line Slides...
Request Info...
HSV 1 IgM...
Biology Products: